Is Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report

Basit Öğe Kaydı
dc.authoridTURGAY YILDIRIM, OZGE/0000-0002-6731-4958
dc.authoridHuseyinoglu Aydin, Ayse/0000-0002-3056-9981
dc.authoridAYDIN, Fatih/0000-0002-1017-1917
dc.contributor.authorAydin, Fatih
dc.contributor.authorYildirim, Ozge Turgay
dc.contributor.authorAydin, Ayse Huseyinoglu
dc.contributor.authorDagtekin, Evrin
dc.contributor.authorAksit, Ercan
dc.date.accessioned2025-01-27T21:01:48Z
dc.date.available2025-01-27T21:01:48Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractLeft ventricular thrombi are mostly seen in the akinetic segments of left ventricle and warfarin is the golden standard treatment. In our case, a 67-year-old male patient with ischemic dilated cardiomyopathy and atrial fibrillation was under warfarin treatment, but due to fluctuations in international normalized ratio, warfarin was discontinued and changed to rivaroxaban (20 mg once a day). He had a fixed thrombus measuring 1.80 x 1.12 cm(2) in the left ventricle under warfarin treatment before rivaroxaban use. After 6 months of rivaroxaban treatment, the thrombus regressed to 1.54 x 1.06 cm(2) without any embolic episode or bleeding. This case supports the finding that rivaroxaban can be a safe alternative to warfarin when warfarin cannot be used.
dc.identifier.doi10.1016/j.jstrokecerebrovasdis.2018.04.015
dc.identifier.endpageE205
dc.identifier.issn1052-3057
dc.identifier.issn1532-8511
dc.identifier.issue9
dc.identifier.pmid29735275
dc.identifier.scopus2-s2.0-85046674773
dc.identifier.scopusqualityQ1
dc.identifier.startpageE203
dc.identifier.urihttps://doi.org/10.1016/j.jstrokecerebrovasdis.2018.04.015
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27190
dc.identifier.volume27
dc.identifier.wosWOS:000441086000004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.ispartofJournal of Stroke & Cerebrovascular Diseases
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectRivaroxaban
dc.subjectapical thrombus
dc.subjectatrial fibrillation
dc.subjectheart failure
dc.titleIs Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu